The immunogenicity and reactogenicity of a new DTPw-HBV vaccine as a primary and booster vaccination course in healthy infants

Human Vaccines

Volumn 3, Issue 4, 2007, Pages 121-126

  Prymula, Roman ^a   David, Marie Pierre ^b   Lefevre, Inge ^b   Kohl, Igor ^c   Štefkovičová, Mária ^d  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^c GLAXOSMITHKLINE   (United Kingdom)

^d Regional Public Health Authority   (Slovakia)

Author keywords

Booster vaccination; Combination paediatric vaccines; Diphtheria; DTPw; DTPw HBV; Primary vaccination; Tetanus; Whole cell pertussis

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; RECOMBINANT HEPATITIS B VACCINE; TRIPLE ANTIGEN; UNCLASSIFIED DRUG;

ANOREXIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG SAFETY; ERYTHEMA; FEMALE; FEVER; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOREACTIVITY; INFANT; INJECTION SITE SWELLING; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; PAIN; PERTUSSIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TETANUS; VACCINATION;

EID: 34848864523     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.3.4.4094     Document Type: Article

References (11)

1. World health organisation (WHO). Pertussis vaccines - WHO position paper. Wkly Epidemiol Rec 2005; 80:31-9.
2. World health organisation (WHO). Facts sheets. Hepatitis B: Fact Sheet no 204. Revised 2000.
3. Arístegui J, Garrote E, Gonzàlez A, Arrate JP, Perez A, Vandepapelière P. Immune response to a combined Hepatitis B, Diphtheria, Tetanus and whole cell Pertussis vaccine administered at 2, 4 and 6 months of age. Vaccine 1997; 151:7-9.
4. Diez-Delgado J, Dal-Ré R, Llorente M, Gonzàlez A, Lòpez J. Hepatitis b component does not interfere with the immune response to diphtheria, tetanus and whole cell Bordetella Pertussis components of a quadrivalent (DTPw-HBV) vaccine: A controlled trial in infants. Vaccine 1997; 15:1418-22.
5. Poovorawan Y, Theamboonlers A, Sanpavat S, Chongsrisawat V, Willems P, Safary A. Comparison study of combined DTPw-HBV vaccines and separate administration of DTPw and HB vaccines in Thai children. Asian Pac J Allergy Immuno 1999; 17:113-20.
6. Prikazsky V, Bock H. Higher anti-hepatitis B response with combined DTPw-HBV vaccine compared with separate administration in healthy infants at 3, 4 and 5 months of age in Slovakia. Int J Clin Pract 2001; 55:156-61.
7. Wenger J. Vaccines for the developing world: current status and future directions. Vaccine 2001; 19:1588-91.
8. Godfroid F, Denoel P, De Grave D, Schuerman L, Poolman J. Diphtheria-Tetanus-Pertus sis (DTP) combination vaccines and evaluation of pertussis immune response. Int J Med Microbiol 2004; 294:269-76.
9. Gatchalian S, Reyes M, Bernal N, Lefevre I, David MP, Han HH, Bock HL, Wolter J, Schuerman L. A new DTPw-HBV vaccine mixed with PRP-T is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following Hepatitis B vaccination at birth. Human Vaccines 2005; 1:198-203.
10. Arístegui J, Usonis V, Coovadia H, Riedemann S, Win KM, Gatchalian S, Bock H, Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. Int J Infect Dis 2003; 7:143-51.
11. Santos J, Martin A, De Leon T, Rivera L, Gaitan ME, Del Rio C, Oselka G, Cervantes Y, Rubio P, Clemens SA, de Mendonca JS. DTPw-HP and Hib primary and booster vaccination: Combined versus separate administration to Latin American children. Vaccine 2002; 20:1887-93.